Enhertu, an oncology drug by AstraZeneca, led new drug sales in 2024 with Rs 58 crore, reflecting rising cancer cases. Over 3 ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

with some blood pressure medications and anti-depressants and, to a lesser extent, diabetes medication associated with a decreased risk of dementia and others associated with increased risk.

The new class of anti-obesity medications has become some of the most sought-after prescription drugs in history. According ...

The authors point out that other classes of drugs, including those treating erectile dysfunction and an anti-arrythmic drug ... first place because they have diabetes or obesity, as well as ...

US-based pharmaceutical company Eli Lilly is planning to launch Mounjaro, an anti-diabetes and weight loss drug in India by 2025 after regulatory approvals, reported News18 citing officials from ...

The study suggests that cannabinoids exhibit multi-target binding to key type 2 diabetes drug targets, indicating their potential for further investigation as anti-diabetic agents. With 537 ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But reports of unpleasant side effects have prompted further studies. This ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD ... suggested these drugs might have anti-inflammatory and lung-protective effects.

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.

He also spoke of metformin, an anti-diabetic drug now being used for anti-ageing. Mr. Ramakrishnan said that both had to undergo systematic study, clinical trials, and safety tests, but people ...

Participants were aged 20–70 years with a body mass index (BMI) greater than 25 and were not taking any anti-diabetic medication other than metformin. After excluding patients with a range of ...